Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Athenex, Inc. (ATNX)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North America and Asia. It operates in three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. Its Orascovery product candidates also comprise Oradoxel, an oral dosage form of docetaxel, which is in Phase I clinical study for breast, lung, prostate, gastric, and head and neck cancers; Oratopo, an oral dosage form of topotecan that is Phase I clinical trial to treat lung, ovarian, and cervical cancer; and oral eribulin, an intravenous anticancer drug to treat certain patients with breast cancer and advanced liposarcoma. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-06 CAMPBELL KIM Director Buy 1,750 $4.03 $7,052 No
2021-05-06 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 5,000 $3.99 $19,950 No
2021-04-05 CAMPBELL KIM Director Buy 8,250 $4.42 $36,465 No
2021-03-04 Zuo William Wei President, China Division Sell 419,931 $4.52 $1,898,088 No
2021-03-03 WU JINN Director Sell 98,000 $4.75 $465,500 No
2020-12-01 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 1,000 $13.31 $13,310 No
2020-11-10 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 1,000 $11.95 $11,950 No
2020-11-06 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 5,000 $11.70 $58,500 No
2020-09-24 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 1,000 $11.95 $11,950 No
2020-09-21 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 1,000 $12.42 $12,420 No
2020-09-10 Davis Stephanie A Director Buy 10,000 $11.35 $113,500 No
2020-09-10 Davis Stephanie A Director Buy 10,000 $11.35 $113,500 No
2020-09-12 Fok Manson Director Buy 30,000 $11.19 $335,763 No
2020-09-11 WU JINN Director Buy 10,000 $11.05 $110,500 No
2020-09-14 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 2,000 $11.43 $22,860 No
2020-09-14 PERCEPTIVE ADVISORS LLC 10%-Owner Buy 2,000,000 $11.02 $22,048,000 No
2020-09-10 Kanfer Jordan Director Buy 450 $11.49 $5,170 No
2020-09-10 WU JINN Director Buy 20,000 $11.15 $223,000 No
2020-09-11 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 2,000 $10.99 $21,978 No
2020-09-10 Sze Randoll Chief Financial Officer Buy 1,000 $11.40 $11,400 No
2020-09-10 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 10,000 $11.22 $112,200 No
2020-06-22 Kwan Rudolf EVP, Chief Medical Officer Buy 1,000 $12.82 $12,820 No
2020-06-22 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 2,000 $12.81 $25,620 No
2020-03-27 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 1,000 $7.88 $7,880 No
2020-03-27 Sze Randoll Chief Financial Officer Buy 1,000 $8.19 $8,190 No
2020-03-25 Fok Manson Director Buy 50,000 $7.25 $362,500 No
2020-03-23 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 1,000 $6.64 $6,640 No
2020-03-20 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 1,000 $6.85 $6,850 No
2020-03-18 Kwan Rudolf EVP, Chief Medical Officer Buy 4,000 $5.90 $23,584 No
2020-03-19 LAU JOHNSON YIU NAM CEO and Chairman of the Board Buy 2,000 $6.60 $13,200 No

Insider Smart

Liberty Media Corp (LSXMA) - BERKSHIRE HATHAWAY INC, Buffett made a move and add 2M shares to their position. What a news after dumping Airlines.